Daniel Stauder
Stock Analyst at JMP Securities
(3.41)
# 902
Out of 4,847 analysts
17
Total ratings
56.25%
Success rate
4.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Reiterates: Market Outperform | $33 | $28.45 | +15.99% | 4 | May 6, 2025 | |
| ATRC AtriCure | Reiterates: Market Outperform | $60 | $34.73 | +72.76% | 6 | Apr 30, 2025 | |
| STIM Neuronetics | Maintains: Market Outperform | $3 → $7 | $3.86 | +81.35% | 1 | Mar 5, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $82.51 | +33.32% | 4 | Feb 28, 2025 | |
| AXON Axon Enterprise | Reiterates: Market Outperform | $725 | $759.07 | -4.49% | 1 | Feb 26, 2025 | |
| AVNS Avanos Medical | Reiterates: Market Perform | n/a | $12.45 | - | 1 | May 7, 2024 |
Artivion
May 6, 2025
Reiterates: Market Outperform
Price Target: $33
Current: $28.45
Upside: +15.99%
AtriCure
Apr 30, 2025
Reiterates: Market Outperform
Price Target: $60
Current: $34.73
Upside: +72.76%
Neuronetics
Mar 5, 2025
Maintains: Market Outperform
Price Target: $3 → $7
Current: $3.86
Upside: +81.35%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $82.51
Upside: +33.32%
Axon Enterprise
Feb 26, 2025
Reiterates: Market Outperform
Price Target: $725
Current: $759.07
Upside: -4.49%
Avanos Medical
May 7, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $12.45
Upside: -